Chang CH - Search Results

1

Selective and Concentrated Accretion of SN-38 with a CEACAM5-Targeting Antibody-Drug Conjugate (ADC), Labetuzumab Govitecan (IMMU-130).

Sharkey RM, Govindan SV, Cardillo TM, Donnell J, Xia J, Rossi EA, Chang CH, Goldenberg DM. Sharkey RM, et al. Among authors: chang ch. Mol Cancer Ther. 2018 Jan;17(1):196-203. doi: 10.1158/1535-7163.MCT-17-0442. Epub 2017 Oct 27. Mol Cancer Ther. 2018. PMID: 29079710

2

Molecular advances in pretargeting radioimunotherapy with bispecific antibodies.

Chang CH, Sharkey RM, Rossi EA, Karacay H, McBride W, Hansen HJ, Chatal JF, Barbet J, Goldenberg DM. Chang CH, et al. Mol Cancer Ther. 2002 May;1(7):553-63. Mol Cancer Ther. 2002. PMID: 12479274 Review.

3

Radioimmunotherapy: is avidin-biotin pretargeting the preferred choice among pretargeting methods?

Goldenberg DM, Chang CH, Sharkey RM, Rossi EA, Karacay H, McBride W, Hansen HJ, Chatal JF, Barbet J. Goldenberg DM, et al. Among authors: chang ch. Eur J Nucl Med Mol Imaging. 2003 May;30(5):777-80. doi: 10.1007/s00259-002-1089-6. Epub 2003 Feb 6. Eur J Nucl Med Mol Imaging. 2003. PMID: 12574971 No abstract available.

4

Development of new multivalent-bispecific agents for pretargeting tumor localization and therapy.

Rossi EA, Sharkey RM, McBride W, Karacay H, Zeng L, Hansen HJ, Goldenberg DM, Chang CH. Rossi EA, et al. Among authors: chang ch. Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):3886S-96S. Clin Cancer Res. 2003. PMID: 14506187

5

Reagents and methods for PET using bispecific antibody pretargeting and 68Ga-radiolabeled bivalent hapten-peptide-chelate conjugates.

Griffiths GL, Chang CH, McBride WJ, Rossi EA, Sheerin A, Tejada GR, Karacay H, Sharkey RM, Horak ID, Hansen HJ, Goldenberg DM. Griffiths GL, et al. Among authors: chang ch. J Nucl Med. 2004 Jan;45(1):30-9. J Nucl Med. 2004. PMID: 14734668 Free article.

6

Improved targeting of pancreatic cancer: experimental studies of a new bispecific antibody, pretargeting enhancement system for immunoscintigraphy.

Cardillo TM, Karacay H, Goldenberg DM, Yeldell D, Chang CH, Modrak DE, Sharkey RM, Gold DV. Cardillo TM, et al. Among authors: chang ch. Clin Cancer Res. 2004 May 15;10(10):3552-61. doi: 10.1158/1078-0432.CCR-03-0340. Clin Cancer Res. 2004. PMID: 15161715

7

Development of humanized antibodies as cancer therapeutics.

Qu Z, Griffiths GL, Wegener WA, Chang CH, Govindan SV, Horak ID, Hansen HJ, Goldenberg DM. Qu Z, et al. Among authors: chang ch. Methods. 2005 May;36(1):84-95. doi: 10.1016/j.ymeth.2005.01.008. Methods. 2005. PMID: 15848077

8

Improved pretargeted delivery of radiolabelled hapten to human tumour xenograft in mice by avidin chase of circulating bispecific antibody.

Mirallié E, Saï-Maurel C, Faivre-Chauvet A, Regenet N, Chang CH, Goldenberg DM, Chatal JF, Barbet J, Thedrez P. Mirallié E, et al. Among authors: chang ch. Eur J Nucl Med Mol Imaging. 2005 Aug;32(8):901-9. doi: 10.1007/s00259-005-1811-2. Epub 2005 Apr 30. Eur J Nucl Med Mol Imaging. 2005. PMID: 15864584

9

Effective therapy of human lymphoma xenografts with a novel recombinant ribonuclease/anti-CD74 humanized IgG4 antibody immunotoxin.

Chang CH, Sapra P, Vanama SS, Hansen HJ, Horak ID, Goldenberg DM. Chang CH, et al. Blood. 2005 Dec 15;106(13):4308-14. doi: 10.1182/blood-2005-03-1033. Epub 2005 Aug 18. Blood. 2005. PMID: 16109781 Free article.

10

Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methods.

Sharkey RM, Karacay H, Cardillo TM, Chang CH, McBride WJ, Rossi EA, Horak ID, Goldenberg DM. Sharkey RM, et al. Among authors: chang ch. Clin Cancer Res. 2005 Oct 1;11(19 Pt 2):7109s-7121s. doi: 10.1158/1078-0432.CCR-1004-0009. Clin Cancer Res. 2005. PMID: 16203810

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,933 results

Search Page